Resveratrol upregulates the agonistic receptors DR4 and DR5 in androgen-insensitive human prostate carcinoma cells PC-3 and DU-145 [122], enhancing TRAIL sensitivity and possibly facilitating NK cell-mediated killing. The gene discussed is TNFRSF10A; the disease is prostate carcinoma.